553 results
Page 5 of 28
8-K
EX-2.1
bpriklfrr4v0422ca
10 Aug 20
Tender and Support Agreement
9:48pm
8-K
EX-99.1
ijn37x07j80v68w3oc
10 Aug 20
Tender and Support Agreement
9:48pm
8-K
inwuf 6b82k37lwwbgq2
11 Jun 20
Submission of Matters to a Vote of Security Holders
4:12pm
8-K
n680a 2rn
16 Oct 19
Ligand Appoints Pharmaceutical Executive Sarah Boyce to its Board of Directors
8:57am
S-8
d7i5u56nhthn7a6e6
8 Aug 19
Registration of securities for employees
4:25pm
S-8
EX-23.1
tw2fap
8 Aug 19
Registration of securities for employees
4:25pm
8-K
ar61co sgykw6f
10 Jun 19
Departure of Directors or Certain Officers
4:11pm
DEFA14A
3zmc nw0smh
4 Jun 19
Additional proxy soliciting materials
5:07pm
8-K
EX-99.1
yp0f1d 7tjn7oe2
2 May 19
Ligand Reports First Quarter 2019 Financial Results
4:09pm
8-K
EX-99.1
bdqej2t0 rs2qfs3toji
12 Mar 19
Regulation FD Disclosure
10:02am
8-K
EX-2.1
rr5fz0jw
5 Mar 19
Entry into a Material Definitive Agreement
5:16pm